Form 4: Integer Holdings Director Awarded 1,967 Stock Units

Director James F. Hinrichs received a grant of 1,967 restricted stock units as part of his compensation package at Integer Holdings Corp.

Summary

• James F. Hinrichs, a member of the Board of Directors, was granted 1,967 Restricted Stock Units (RSUs) on May 20, 2026.
• The RSUs convert into common stock on a one-for-one basis upon vesting.
• Vesting occurs in four approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027.
• The reporting person has elected to defer the settlement of the common stock until separation from service as a director or a change in control of the company.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event, as it confirms the continued engagement and alignment of a key board member with the company's equity performance.

Positives

• Aligns director interests with those of long-term shareholders through equity-based compensation.
• The election to defer settlement until separation from service suggests a long-term commitment to the company's performance.
• Structured quarterly vesting schedule ensures continuous service incentive over the next year.

Negatives

• The grant represents a potential, albeit small, dilution of existing shareholder equity.
• This is a compensation-based grant rather than an open-market purchase, which provides less of a signal regarding the director's view on current stock valuation.

Risks

• The ultimate value of the compensation is subject to market volatility and the future share price of ITGR.
• Settlement is contingent upon continued service or specific corporate events like a change in control.

Future Outlook

The director will continue to vest in these units through May 2027, maintaining a vested interest in the company's long-term stock performance. The deferred settlement indicates that these shares will not enter the public float until the director leaves the board or the company is acquired.

Management Comments

• The reporting person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer.

Industry Context

StockSavvy.ai notes that equity grants for non-employee directors are a standard industry practice for mid-cap medical technology firms to ensure board members are incentivized to drive shareholder value.

Comparison to Industry Standards

• The grant size is consistent with director compensation packages at peer medical device outsourcing firms such as Teleflex or Merit Medical Systems.
• Quarterly vesting is a common structure for annual director equity retainers in the S&P 400 MidCap index.

Corporate Governance

Related Party Transactions

• The grant of RSUs to James F. Hinrichs constitutes a transaction between the issuer and an insider (Director).

Stakeholder Impact

• Shareholders benefit from having directors whose compensation is tied to the long-term stock price.
• No immediate impact on customers, employees, or creditors.

Next Steps

• The first vesting installment is scheduled for August 20, 2026.
• The director will continue to serve on the board through the 2026-2027 term.

Key Dates

Recommendation

This is a routine Form 4 filing for director compensation and does not provide new material information regarding the company's operational performance or financial health that would warrant a change in investment rating.

Keywords

Integer Holdings, ITGR, Form 4, Insider Trading, Restricted Stock Units, Director Compensation, James Hinrichs, Medical Device Components